Elsayed Soliman to Platelet Aggregation Inhibitors
This is a "connection" page, showing publications Elsayed Soliman has written about Platelet Aggregation Inhibitors.
Connection Strength
0.532
-
Kamel H, Zhang C, Kleindorfer DO, Levitan EB, Howard VJ, Howard G, Soliman EZ, Johnston SC. Association of Black Race With Early Recurrence After Minor Ischemic Stroke or Transient Ischemic Attack: Secondary Analysis of the POINT Randomized Clinical Trial. JAMA Neurol. 2020 05 01; 77(5):601-605.
Score: 0.172
-
Dawood FZ, Judd S, Howard VJ, Limdi NA, Meschia JF, Cushman M, Howard G, Herrington DM, Soliman EZ. High-Sensitivity C-Reactive Protein and Risk of Stroke in Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke Study). Am J Cardiol. 2016 Dec 15; 118(12):1826-1830.
Score: 0.134
-
Soliman EZ, Mendis S, Dissanayake WP, Somasundaram NP, Gunaratne PS, Jayasingne IK, Furberg CD. A Polypill for primary prevention of cardiovascular disease: a feasibility study of the World Health Organization. Trials. 2011 Jan 05; 12:3.
Score: 0.090
-
Viera AJ, Sheridan SL, Edwards T, Soliman EZ, Harris R, Furberg CD. Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians. Prev Med. 2011 Jan; 52(1):10-5.
Score: 0.088
-
Reading Turchioe M, Soliman EZ, Goyal P, Merkler AE, Kamel H, Cushman M, Soroka O, Masterson Creber R, Safford MM. Atrial Fibrillation and Stroke Symptoms in the REGARDS Study. J Am Heart Assoc. 2022 01 18; 11(2):e022921.
Score: 0.048